1. Home
  2. DRUG vs BVS Comparison

DRUG vs BVS Comparison

Compare DRUG & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$78.45

Market Cap

778.4M

Sector

Health Care

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$14.34

Market Cap

783.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRUG
BVS
Founded
2019
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
778.4M
783.2M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
DRUG
BVS
Price
$78.45
$14.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$129.25
$14.00
AVG Volume (30 Days)
176.6K
810.2K
Earning Date
05-15-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
163.46
EPS
N/A
0.52
Revenue
N/A
$568,087,000.00
Revenue This Year
N/A
$7.52
Revenue Next Year
N/A
$7.06
P/E Ratio
N/A
$27.56
Revenue Growth
N/A
N/A
52 Week Low
$38.00
$6.26
52 Week High
$123.75
$15.89

Technical Indicators

Market Signals
Indicator
DRUG
BVS
Relative Strength Index (RSI) 52.92 61.47
Support Level $76.54 $7.29
Resistance Level $83.65 $15.89
Average True Range (ATR) 3.86 0.78
MACD -0.01 -0.06
Stochastic Oscillator 37.03 51.67

Price Performance

Historical Comparison
DRUG
BVS

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: